Oliver is an associate in our Life Sciences and Chemistry group. He is a European patent attorney, chartered UK patent attorney and is registered to represent clients before the Unified Patent Court (UPC).
He specialises in biotechnology, advising a broad spectrum of clients on a diverse range of technologies, including pharmaceuticals, vaccine technology, mRNA therapies, biomarkers, synthetic biology, gene therapy and enzymology. Oliver has considerable experience in mRNA technology, particularly vaccine formulation, and used this to support a large international litigation relating to COVID-19 vaccines.
His passion is to work closely with his clients to deliver bespoke patenting strategies resulting in optimum protection. As well as being an expert in patent prosecution, Oliver advises on patent infringement, validity, and EPO opposition matters.
His understanding of his clients’ needs has been honed by a secondment in the patent department of a multinational pharmaceutical and biotechnology company, and prior to becoming a patent attorney, working at the biopharmaceutical company UCB, where he specialised in antibody discovery using phage display technology.
Previously, Oliver graduated with a MSci (Hons) in Natural Sciences (Biology and Physics) from The University of Nottingham. After developing a keen interested in patents, he then went on to study an MSc in Management of Intellectual Property at Queen Mary University of London and was awarded the Herchel Smith Scholarship in 2016/17.